 - History of prior malignancy within the past 3 years except for curatively treated basal cell carcinoma and squamous cell carcinoma of the skin, CIN or localized prostate cancer with a current PSA 1.0 mgdL on 2 successive evaluations at least 3 months apart, with the most recent evaluation within 4 weeks of study entry 